For informational purposes only—not medical advice.
Affiliate disclosure: We earn commissions from some providers on this page. This does not affect our rankings. We have declined partnerships with providers that did not meet our standards.
To identify the highest-rated GLP-1 providers, we compared verified pricing, medication type, pharmacy transparency, insurance support, cancellation terms, real patient reviews across Trustpilot and other platforms, and FDA regulatory history for every major online option.
For FDA-approved medication with insurance support, Ro is the strongest overall pick. LegitScript-certified, focused on FDA-approved GLP-1s like Wegovy and Zepbound, lab testing included when your provider orders it, and a dedicated insurance concierge that handles prior authorizations for you. Membership starts at $39 for month one, then $149/month — medication costs are separate and depend on your coverage.
For compounded GLP-1 medication (cash-pay), MEDVi is one of the most-reviewed compounded providers we found — over 10,500 on Trustpilot at a 4.5-star rating — with compounded semaglutide starting at $179 for month one. SkinnyRx earns the highest star rating among providers we feature at 4.8 stars across 4,000+ reviews, with free overnight shipping on every order.
If you hate needles, Hims & Hers announced a March 2026 deal with Novo Nordisk to offer FDA-approved oral Wegovy starting as low as $149/month — availability is still rolling out and not yet in all 50 states.
The honest part most comparison pages skip: The FDA sent 30 warning letters to telehealth companies in March 2026 for misleading marketing of compounded GLP-1 products (FDA, March 3, 2026). These letters targeted marketing language — not medication safety — but you deserve to know which providers received them and which did not. We disclose this for every affected provider below.
Skip to the section that matches your priority — every recommendation links to a full review below.
If You Have Insurance and Want FDA-Approved Medication → Ro
Ro focuses on FDA-approved GLP-1s: Wegovy, Foundayo (orforglipron), Zepbound, and Ozempic. Their insurance concierge contacts your insurer, submits prior authorizations, and fights for coverage. The membership includes metabolic lab testing through Quest when your provider orders it — a safety step most online providers skip.
Ro is not the cheapest cash-pay option. If your only priority is the absolute lowest monthly price and you’re comfortable with compounded medication, MEDVi or Yucca will cost less. But because Ro emphasizes FDA-approved options, every core medication path is FDA-approved, pharmacy partners are retail-grade, and your insurance might cover it. The $39 first month makes it low-risk to find out what your insurance actually covers.
If You’re Paying Cash and Want the Most-Reviewed Compounded Provider → MEDVi
Over 10,500 verified Trustpilot reviews at a 4.5-star rating — one of the largest review bases of any compounded provider we evaluated. Compounded semaglutide starts at $179 for month one. No contracts. Month-to-month billing. 24/7 support access. Partner pharmacies include Belmar Pharma Solutions (named on MEDVi’s site).
If you’re spending $179–$299/month on your health, you want to know that thousands of people walked the same path before you and came out the other side satisfied. That social proof is MEDVi’s strongest asset.
If You Want the Highest-Rated Provider With Fast Shipping → SkinnyRx
4.8 stars across 4,000+ Trustpilot reviews — the highest star rating of any provider on this list. Free overnight shipping is standard (not an upgrade). Both injectable and tablet options.
If speed matters and you want a provider whose patients consistently rate it near-perfect, SkinnyRx delivers.
If You Want Flat Pricing That Never Increases → Eden
Eden charges the same monthly rate regardless of your dose — genuinely rare. Most providers advertise a low starting price that climbs as you titrate higher. Eden absorbs that difference. They also offer both compounded and FDA-approved options (Ozempic, Wegovy, Zepbound, Mounjaro), making them more flexible than most compounded-only platforms. Compounded semaglutide from $129 first month, then $209/mo on a 3-month plan or $229/mo monthly.
If You Want FDA-Approved Pills (No Needles) → Hims & Hers
Hims announced a March 2026 partnership with Novo Nordisk to roll out branded Wegovy (including the oral pill) and Ozempic. Cash-pay from $149/month. Availability is expanding but not yet in all 50 states.
~$146/month on a 6-month plan — lowest verified rate we’ve found. Approximately 915 Trustpilot reviews at 4.5 TrustScore. Many patients use HSA/FSA (though Yucca does not provide itemized receipts or letters of medical necessity). Fast UPS 2-Day Air shipping.
Ro — Best Overall for Legitimacy and Insurance Support
No warning letters LegitScript Certified
Bottom line: Ro is the safest default for anyone who has insurance or wants FDA-approved medication with real clinical backing. If you’re unsure where to start, start here.
What they offer
Ro focuses on FDA-approved GLP-1 medications: Wegovy (semaglutide), Foundayo (orforglipron), Zepbound (tirzepatide KwikPen and vials), and Ozempic (semaglutide). The Ro Body membership includes:
Initial telehealth consultation with a licensed provider
Metabolic lab testing through Quest when your provider orders it (included; at-home kit $75 or free if Quest isn't available in your state)
The pricing structure confuses some people at first because the membership and medication are billed separately. Many negative Ro reviews on Trustpilot appear to trace to this misunderstanding — people expecting $39/month to cover everything. It doesn’t. The membership covers the clinical team, coaching, lab work, and insurance concierge. Medication is billed separately, either through insurance or cash-pay. Once patients understand this model, satisfaction is consistently strong.
Here’s what most people miss about insurance: getting denied on the first prior authorization attempt is normal. Insurance companies deny GLP-1 requests at high rates on the initial submission. That’s not a sign that it won’t be covered — it’s standard operating procedure for insurers. The difference is what happens after that first “no.” Most patients give up. Ro’s concierge team doesn’t. They appeal. They try alternative medications. They use different justification codes. This is how Ro earns its membership fee for insurance patients.
And if insurance still doesn’t come through, your provider pivots to cash-pay — and because Ro has direct integrations with NovoCare (Novo Nordisk’s pharmacy) and LillyDirect (Eli Lilly’s pharmacy), you get the same low prices as the manufacturers themselves. No middleman, no markup. Oral Wegovy through NovoCare starts at $149/month for the 1.5 mg dose. Zepbound vials through LillyDirect start at $299/month.
Trust signals
LegitScript-certified — independently verified for regulatory compliance
Emphasizes FDA-approved medications
Named pharmacy partners (NovoCare, LillyDirect, retail pharmacies)
Lab work included when provider orders it
No FDA warning letters
Transparent cancellation: anytime with 48 hours' notice before billing date
Ro is for you if:
• You have commercial insurance and want GLP-1 coverage help
• You prioritize FDA-approved medication
• You want labs, structured follow-up, and real coaching
Ro is NOT for you if:
• You’re on Medicaid (not eligible)
• Your only goal is the lowest monthly price
• You’re comfortable with compounded and want under $180/mo
Our take: The $39 first month is a low-risk way to find out if your insurance covers GLP-1 treatment. If it does, the total cost with Ro can actually come in lower than compounded cash-pay — $784 in membership plus copays vs. $1,100+ for six months of compounded. If it doesn’t work out, cancel before the $149 kicks in. You risk $39 to potentially save hundreds over six months. That’s a good bet.
MEDVi — Most-Reviewed Compounded Provider We Feature
FDA letter (marketing) 20264.5★(10,500+ reviews)
Bottom line: MEDVi has one of the largest verified review bases of any compounded GLP-1 provider — over 10,500 on Trustpilot at 4.5 stars. For cash-pay patients who want massive social proof and real support access, MEDVi is the front-runner among the providers we evaluated.
What they offer
Compounded semaglutide and tirzepatide (injections and oral tablets). MEDVi says care is delivered by affiliated U.S.-licensed clinician networks and partner pharmacies, including Belmar Pharma Solutions on some of its GLP-1 pages. No contracts — true month-to-month billing. 24/7 support access via messaging.
Important: Compounded medications are not FDA-approved. They have not been reviewed by the FDA for safety, effectiveness, or quality.
What it costs (provider-stated, March 2026)
• Compounded semaglutide injection: $179 first month, $299/month ongoing
• Compounded semaglutide tablets: $249 first month, refill pricing varies
• Compounded tirzepatide: From $279 first month, $399/month ongoing
• No membership fee. Price includes consultation, medication, shipping, and support access.
How the process works (provider-stated)
You start with a free online health evaluation. A licensed physician from MEDVi’s affiliated clinician network reviews your answers and determines eligibility. If approved — and not everyone is; the screening is real — your provider creates a treatment plan with medication type, dosing, and titration schedule. Your prescription ships from a licensed U.S. compounding pharmacy in temperature-controlled packaging. Most patients receive medication within a few days of approval. From there, you have 24/7 messaging access to your care team for side-effect questions, dose adjustments, and ongoing check-ins.
What 10,500+ patients say
The sheer volume of reviews is the story here. At 10,500+ on Trustpilot, MEDVi has a dataset that smaller providers can’t match. Based on our review of Trustpilot feedback, clear patterns emerge. The consistent positives: quick approval process, responsive support team, effective medication, and transparent pricing. Patients frequently mention that the process felt personal rather than automated, which is notable given MEDVi’s scale. Negative reviews typically mention shipping timing expectations and occasional support wait times during high-volume periods.
FDA disclosure: MEDVi received an FDA warning letter in February 2026 regarding marketing claims — same category as 29 other companies in the same batch. The letter cited marketing language, not medication safety or a product recall. MEDVi’s operational model (support access, pharmacy partnership, review volume) remains intact. We disclose this because you deserve complete information.
SkinnyRx — Highest Star Rating and Fastest Shipping
FDA letter (marketing) 20264.8★(4,000+ reviews)
Bottom line: 4.8 stars on Trustpilot across 4,000+ reviews — the highest star rating of any provider on this page. Free overnight shipping on every order, not as an upgrade, not on certain plans — every order. If you want a provider whose patients rate it near-perfect and you want your medication fast, SkinnyRx is built for that.
What they offer
Compounded semaglutide and tirzepatide in multiple formats: injectable, sublingual, and tablet. Licensed providers review every application. Both monthly and multi-month plans available, with better rates on longer commitments. Operated by Lean Rx, Inc. out of Sacramento, California. Compounded medications are not FDA-approved.
What it costs (provider-stated, March 2026)
• From $199/month. Multi-month plans lower the effective monthly rate.
• Price includes consultation, medication, supplies, and free overnight shipping.
• Pricing does not change based on dose (verify current plan terms at checkout).
What 4,000+ patients say
The 4.8-star Trustpilot rating at this scale is genuinely impressive — maintaining near-perfect satisfaction across thousands of patients requires consistent execution. The patterns in reviews: fast shipping (the overnight standard is the most frequently praised feature), professional providers, straightforward signup, and responsive support. Negative reviews are relatively rare and typically mention communication delays during peak-volume periods — which is a capacity issue, not a quality-of-care issue.
The Sacramento-based operation means West Coast patients often get same-day or next-day delivery, and East Coast patients typically receive medication within 1–2 business days. Speed matters when you’re motivated to start.
FDA disclosure: FDA warning letter issued in early 2026 regarding website marketing claims and product-source labeling — not a recall or shutdown. Same category as MEDVi: the letter cited claims implying equivalence with FDA-approved products. Thirty companies received similar letters in the same period. SkinnyRx’s operational model remains intact.
SkinnyRx is for you if:
• You value speed, simplicity, and a near-perfect satisfaction record
• You want multiple medication formats
• You’re willing to commit to multi-month for best rates
Eden — Best for Flat Pricing (Compounded + FDA-Approved)
4.3★(~3,000 reviews)
Bottom line: Eden’s pricing doesn’t go up when your dose does — genuinely rare and genuinely valuable over a 6–12 month treatment course. They also offer both compounded and FDA-approved options on the same platform, making them more flexible than most providers in the affordable tier.
What they offer
Compounded semaglutide and tirzepatide, plus FDA-approved options including Ozempic, Wegovy, Zepbound, and Mounjaro. 24/7 coaching access, provider messaging, community support, and free shipping included in your monthly rate. Most patients hear from a board-certified physician within 24–48 hours (provider-stated). Compounded medications are not FDA-approved.
What it costs (provider-stated, March 2026)
• Compounded semaglutide: From $129 first month, then $209/mo (3-month plan) or $229/mo (monthly plan)
• Compounded tirzepatide: From $249 first month, then $329/mo
• FDA-approved options: Pricing varies by drug and plan
The flat-pricing model is the real differentiator. With most compounded providers, your price increases as your dose goes up during titration. You start paying $179/month at 0.25 mg and end up paying $299/month at 1.0 mg or higher. Over a 6-month treatment course, those increases add up to hundreds of dollars more than you budgeted. Eden absorbs the dose increase. Your rate at month one is your rate at month six, regardless of where your dose lands.
What patients say
Approximately 3,000 Trustpilot reviews at 4.3 stars. Eden responds to 99% of negative reviews on the platform — which tells you something about how seriously they take feedback. Positive reviews praise predictable pricing, fast approval times, and responsive support. Negative reviews mention occasional shipping delays and standard compounded-medication concerns.
Bottom line: Hims is in the middle of a major pivot toward branded, FDA-approved GLP-1 access through a March 2026 deal with Novo Nordisk. If the rollout delivers on its promise, Hims could become one of the leading platforms for FDA-approved GLP-1 pills. But it’s not fully there yet.
What changed
On March 9, 2026, Hims and Novo Nordisk announced a formal agreement. Hims will offer injectable Ozempic, injectable Wegovy, and the new oral Wegovy pill at cash-pay prices starting as low as $149/month. Hims agreed to stop advertising compounded GLP-1 products, though the company will continue offering compounded options “if a provider determines that a compounded product is clinically necessary.” The live Hims weight-loss page still references compounded treatment as part of its current program. Sources: Reuters, Hims newsroom.
Important: Branded GLP-1 availability through Hims is still rolling out. GLP-1 offerings are not yet in all 50 states. Verify what’s currently available in your area directly on the platform.
Honest tradeoff: Hims has a complex recent history — including the Novo lawsuit and FDA-related scrutiny over compounded-product marketing. The new deal resolves the legal dispute, but the platform is still in transition. If you want FDA-approved access that’s fully operational right now, Ro is the safer bet today.
Bottom line: ~$146/month on a 6-month plan. That’s the lowest verified rate from a provider meeting our baseline standards.
Compounded semaglutide, shipped UPS 2-Day Air. Approximately 915 Trustpilot reviews at a 4.5 TrustScore. Many patients use HSA/FSA funds (Yucca does not provide itemized receipts or letters of medical necessity). Flexible payment through Affirm, Klarna, Afterpay. Compounded medications are not FDA-approved.
Honest tradeoff: The best rate requires a 6-month commitment. Support is leaner than MEDVi or Eden. Some reviewers report billing confusion around auto-renewals — read terms carefully.
Bottom line: If injections are a dealbreaker, Willow offers compounded oral semaglutide tablets starting at $299/month. Plans include unlimited doctor messaging and personalized dosing. Cancellation requires 2 business days’ notice before the next processing date.
Important: Compounded oral semaglutide is not the same product as FDA-approved oral Wegovy. The formulation, dosing, and absorption profile may differ. If you specifically want FDA-approved oral Wegovy, check Ro or Hims. Compounded medications are not FDA-approved.
FDA-Approved vs. Compounded: What You’re Actually Buying
This is the most important distinction in GLP-1 telehealth. Too many comparison pages blur it — sometimes intentionally, because ambiguity makes it easier to sell compounded products at higher margins. You deserve clarity.
FDA-Approved Brand-Name Medications
Reviewed by FDA for safety, effectiveness, and quality
Made by a named manufacturer (Novo Nordisk or Eli Lilly)
Every batch tested, every dose standardized
May work with insurance or manufacturer savings programs
Examples: Wegovy, Wegovy pill, Zepbound, Ozempic
Without insurance: $149–$1,400/month. With insurance + manufacturer savings cards: potentially $0–$25/month for eligible commercial-plan patients.
Compounded Medications
Prepared by licensed compounding pharmacies
Not FDA-approved — not reviewed for safety or effectiveness
Not the same as generic drugs
Often chosen for self-pay affordability
Requires prescription from a licensed clinician
Compounded products typically cost $129–$399/month, which is why most cash-pay patients choose this route.
The March 2026 Warning Letters — In Context
The FDA’s letters targeted marketing language, not medication itself. The violations: implying compounded products are equivalent to FDA-approved drugs, branding compounded products under the telehealth company’s name to obscure the actual pharmacy source, and making claims suggesting FDA has evaluated these products when it hasn’t. Several providers on this page (MEDVi, SkinnyRx) were among the 30 companies that received letters. We disclose this for every affected provider because transparency is non-negotiable.
FDA Commissioner Marty Makary: “Compounded drugs can be important for overcoming shortages or meeting unique patient needs — but compounders should not try to compound drugs in a way that circumvents FDA’s approval process.”
When to Choose Which
Choose FDA-approved if:
Your insurance covers it (even partially)
You want the highest level of regulatory assurance
You qualify for manufacturer savings programs (NovoCare, LillyDirect)
Safety and regulatory oversight are your top priority
Consider compounded if:
You're paying entirely out of pocket and FDA-approved is out of budget
Your insurance won't cover GLP-1s for weight loss
You understand the tradeoffs and are comfortable with less regulatory oversight
You verify the provider's pharmacy is properly licensed and named
Every provider leads with an intro price. Here’s the real 6-month math — because the intro price is marketing, and the 6-month number is your actual commitment.
•Medication (cash-pay, lowest): Oral Wegovy from $149/mo = ~$894
•6-month cash-pay total: ~$1,664+
•With insurance + copay: potentially $784 + copays only
With insurance coverage, Ro can be the cheapest path on this entire list. If the concierge gets your Wegovy or Zepbound covered and your copay is $25/month, your 6-month total is under $1,000.
•Eden's advantage: your rate doesn't increase at higher doses. With dose-based providers, the actual 6-month total could be $200–$400 higher than projected.
•Branded GLP-1s announced from $149/month at lower doses + membership
•Rollout pricing still being finalized — verify current total directly
Hidden Costs Nobody Talks About
Beyond the headline number, watch for these:
Dose-based price increases — The biggest one. Most compounded providers charge more as your dose goes up. Your "$179 first month" at 0.25 mg becomes $299 at 1.0 mg. Eden is the notable exception with flat pricing at every dose.
Membership fees stacked on medication — Ro charges $149/mo membership PLUS medication costs. Most compounded providers bundle everything. Make sure you're comparing apples to apples.
Lab work — Ro includes metabolic labs when your provider orders them. Most other providers don't require or offer labs. This is a meaningful safety and dosing advantage, but it's "free" only because it's built into the membership.
Shipping — Most providers include it. SkinnyRx includes free overnight. Verify with any provider before assuming.
Cancellation penalties — Ranges from "cancel anytime with 48hr notice" (Ro) to plan-commitment penalties (Yucca on prepaid plans). Always read terms before entering your payment.
The real takeaway:
Compare the 6-month number, not the intro price. And if you have commercial insurance, check what it covers before committing to compounded — because with coverage, the FDA-approved path through Ro could actually save you money while giving you a higher standard of medication.
Insurance is the wild card that changes all the math. If your plan covers GLP-1s, the “cheapest compounded provider” can suddenly cost more than FDA-approved with a $25 copay. But getting coverage approved is hard — insurers deny GLP-1 prior authorizations at high rates, and most patients give up after the first rejection. This is the single most important financial question in your GLP-1 search, and most comparison pages barely touch it.
Insurance Support
Ro offers one of the most comprehensive insurance concierge services in GLP-1 telehealth. They handle the entire process: contacting your insurer, submitting prior authorization, appealing denials, trying alternative medications if the first choice is rejected, and finding cost-saving paths even when full coverage isn’t available. All of this is included in the $149/month membership.
Most commercial insurance plans can cover GLP-1 medication for weight loss, but they make you jump through hoops: documented BMI requirements, weight-related comorbidities, prior authorization forms, specific medication formularies. The process is designed to discourage you. Most people hear “denied” once and assume it means “not covered.” It often doesn’t. It means “submit different paperwork” or “try a different medication on our formulary first.” Ro’s team knows these playbooks because they run them every day across thousands of patients.
Ro cannot coordinate coverage for government plans (Medicare, Medicaid, TRICARE). Medicaid recipients are not eligible for the Ro Body Program. However, Medicare and TRICARE members can join for certain cash-pay medication options.
MEDVi, SkinnyRx, Eden, Yucca, Willow — none of these providers accept or assist with insurance. This is standard across the compounded market. Insurance almost never covers compounded medications for weight loss.
HSA and FSA
Most providers accept Health Savings Account and Flexible Spending Account payments, including Ro, MEDVi, Eden, and Yucca. Documentation requirements vary by plan. Yucca notes it does not provide itemized receipts or letters of medical necessity — check with your HSA/FSA administrator before assuming coverage.
Manufacturer Savings Programs
If you’re prescribed FDA-approved medication, don’t skip this step:
Novo Nordisk (Wegovy, Ozempic): NovoCare savings programs can reduce costs significantly with eligible commercial insurance. Some patients pay as little as $0–$25/month.
Eli Lilly (Zepbound, Mounjaro): LillyDirect programs and savings cards available for eligible commercially insured patients.
These programs are not available for government insurance (Medicare, Medicaid, TRICARE).
If you have commercial insurance and haven’t checked manufacturer savings, do it before committing to a compounded provider. Many people go straight to compounded because they assume FDA-approved is “too expensive.” It often isn’t — especially at lower doses where oral Wegovy starts at $149/month cash-pay, and with a manufacturer savings card plus insurance, could cost you less per month than a gym membership.
The FDA’s BeSafeRx program recommends: valid prescription required, U.S. address and phone number, licensed pharmacist available, state board of pharmacy license. We use these as a baseline and add more. Use this checklist for any provider — including ones not on this page.
Green Flags
1
Requires a real medical evaluation before prescribing — A 2–3 minute health questionnaire asking about medical history, medications, and contraindications is a good sign. A 30-second form that asks for your credit card first is not.
2
Licensed, identifiable clinicians — Named physicians or identified clinical networks with active state licenses.
3
Named pharmacy partners — Ro: NovoCare, LillyDirect, retail. MEDVi: Belmar Pharma Solutions. If a provider won't name the pharmacy, that's a problem.
4
Honest compounded-vs-FDA labeling — Never implies compounded is "the same as" brand-name.
5
Visible cancellation policy — Findable before you pay.
6
Physical contact info — Real phone number, email, business address.
7
LegitScript certification — Independent verification. Ro has it. Not all providers do.
Red Flags — Walk Away
No prescription required
Claims compounded medication is "FDA-approved," "clinically proven," or "the same as" brand-name — exactly what triggered the 2026 warning letters
No named pharmacy
Guaranteed specific weight-loss numbers
Hidden pricing
No medical screening
Quick Check Before You Pay
Use this for any provider. Policies change — what was true six months ago may not be true today.
What to Expect When You Start
If this is your first time considering GLP-1 medication, the process is simpler than most people expect — but there are a few things worth knowing upfront so the first few months go smoothly.
1
Week 1–4: Starting Low
Every reputable provider starts you at a low dose (semaglutide: 0.25 mg/week; tirzepatide: 2.5 mg/week). This isn’t the dose that produces dramatic weight loss — it’s the dose that lets your body adjust to the medication without overwhelming your system.
During this period, you may notice GI side effects. Nausea is the most common and usually mild at this stage. Stay hydrated, eat smaller meals, and give your body time to adapt. Most patients report that these early side effects ease up within a couple of weeks.
But what most patients notice first isn’t the side effects — it’s the quiet. The constant mental chatter about food — what people in the GLP-1 community call “food noise” — starts to fade. The urge to snack. The fixation on what’s for dinner. It gets quieter. Even at the lowest dose, many patients describe this as the moment they realize the medication is actually working — and that this is going to be different from every diet they’ve tried before.
2
Month 2–3: Titrating Up
Your provider gradually increases your dose over several weeks. This is called titration, and it’s the standard protocol for both FDA-approved and compounded GLP-1 medications. The pace depends on how your body responds and how well you tolerate each step up.
This is where clinical oversight earns its price tag. A provider who disappears after shipping your first box isn’t watching for signs you need a slower ramp, a dose hold, or a switch to a different medication format. The difference between a provider that messages you proactively during titration and one that waits for you to complain is the difference between a smooth experience and a frustrating one. Ro (with scheduled check-ins and lab work), MEDVi (with 24/7 messaging access), and Eden (with coaching and provider messaging) all offer stronger support during this critical phase.
3
Month 4+: Maintenance
You’ve reached your therapeutic dose. Weight loss is consistent. The medication is working as intended. Your provider monitors for any need to adjust the dose, manages side effects if they arise, and keeps your prescription current. At this stage, the clinical relationship matters less in terms of hand-holding and more in terms of having a licensed clinician available when you have questions. Most people don’t need much — but knowing it’s there is part of why the best providers earn their fees.
The Commitment Is Real — and That’s Good News
GLP-1 medications are not a quick fix. They work best as part of a sustained commitment — typically 6 to 12 months to reach and maintain meaningful weight loss. The providers on this page that charge more often do so because they offer better support for that longer journey. The cheapest option is the right choice only if you’re self-sufficient enough to manage the process without much hand-holding. Honest self-assessment here will save you money and frustration. Read our guide to maintaining muscle on GLP-1 and our compounded semaglutide safety guide before starting.
What Changed in 2025–2026
The Drug Shortages Ended
The semaglutide injection shortage was resolved February 21, 2025, and the tirzepatide injection shortage was resolved October 2, 2024. While shortages were active, compounding pharmacies had broader legal authority to produce GLP-1 alternatives, and hundreds of telehealth companies sprang up to sell them. That era created a massive, largely unregulated market. Now that branded supply has stabilized, the FDA is tightening enforcement on the companies that grew up in that window. The blanket shortage justification no longer applies for semaglutide injections. Practically, this means the compounded GLP-1 market is undergoing a correction. The providers still standing after the enforcement wave are the ones taking compliance seriously.
The FDA Got Aggressive — 30 Warning Letters in One Month
In March 2026, the FDA issued 30 warning letters to telehealth companies for misleading compounded GLP-1 marketing. This was the second batch since the agency launched its crackdown in September 2025. The FDA reported sending thousands of warning letters to pharmaceutical and telehealth firms over the preceding six months — more than in the entire preceding decade. The letters targeted marketing language — implying compounded products are equivalent to FDA-approved drugs, branding products under the telehealth company’s own trademark to obscure the actual pharmacy source, and making claims suggesting FDA has evaluated these products. This matters for your provider search because it draws a bright line between companies operating transparently and companies whose marketing drew regulatory action.
Oral Wegovy Changed the Entire Calculation
In late 2025, the FDA approved an oral tablet form of Wegovy — the first GLP-1 weight-loss pill. Cash-pay pricing starts at $149/month for lower doses through NovoCare, accessible via providers like Ro. This is a genuine game-changer for two reasons. First, it eliminates the injection barrier — the single biggest reason people who want GLP-1 treatment don’t start it. Second, it narrows the price gap between FDA-approved and compounded medication. A year ago, the cheapest FDA-approved path was $300+/month. Today it starts at $149. For patients at lower doses, the cost difference between FDA-approved oral Wegovy and compounded semaglutide is now minimal — which changes the risk-benefit math entirely.
The Hims & Novo Nordisk Partnership
On March 9, 2026, Hims & Hers and Novo Nordisk announced a formal partnership. Hims will offer branded Wegovy (injection and pill) and Ozempic at cash-pay prices. In exchange, Hims agreed to stop advertising compounded GLP-1 products. Novo Nordisk dropped its patent-infringement lawsuit against Hims. For consumers, this means more competition in the FDA-approved access space — which means better pricing and more options. The branded GLP-1 rollout through Hims is still in progress, but the direction is clear: the industry is shifting toward FDA-approved telehealth access at increasingly competitive prices.
You’ve done something most people don’t — you actually researched this before committing. You know the pricing. The ratings. The regulatory landscape. The honest tradeoffs. You know more about GLP-1 providers right now than 95% of people searching for this information.
The difference between someone who loses weight on GLP-1 medication and someone who doesn’t isn’t the provider they choose. It’s whether they start. The provider matters, but starting matters more. The perfect choice you never act on loses to the good choice you begin today.
Have insurance or want FDA-approved medication?
The $39 first month is the lowest-risk way to find out what your insurance actually covers. Their concierge team may unlock coverage you didn't know you had — and with cash-pay options starting at $149/month, even the out-of-pocket path is more affordable than it used to be.
That’s exactly what the quiz is for. Five questions, sixty seconds, and you’ll have a personalized match based on your insurance, budget, and preferences.
